Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C31H23BrO2S |
| Molecular Weight | 539.482 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]1(CC2=C(C=CC=C2)[C@@]([H])(C1)C3=C(O)C4=C(SC3=O)C=CC=C4)C5=CC=C(C=C5)C6=CC=C(Br)C=C6
InChI
InChIKey=JHELOZJAKXYVBE-YIXXDRMTSA-N
InChI=1S/C31H23BrO2S/c32-24-15-13-20(14-16-24)19-9-11-21(12-10-19)23-17-22-5-1-2-6-25(22)27(18-23)29-30(33)26-7-3-4-8-28(26)35-31(29)34/h1-16,23,27,33H,17-18H2/t23-,27-/m1/s1
| Molecular Formula | C31H23BrO2S |
| Molecular Weight | 539.482 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Cis-Difethialone is an anticoagulant used as a rodenticide. For difenacoum commercial formulations, the cis-isomer is the major form and the trans-isomer is the minor form. Cis-Difethialone inhibit the subunit 1 of the vitamin K epoxide reductase complex this leads to block the formation of the active form of vitamin K, which in turn inhibits the hepatic production of coagulation factors II, VII, IX, and X. Difethialone is not approved for use in Europe but is still used elsewhere.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:50:58 GMT 2023
by
admin
on
Sat Dec 16 05:50:58 GMT 2023
|
| Record UNII |
G9O3YAS31K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
G9O3YAS31K
Created by
admin on Sat Dec 16 05:50:58 GMT 2023 , Edited by admin on Sat Dec 16 05:50:58 GMT 2023
|
PRIMARY |